Home/Filings/4/0001213900-25-112295
4//SEC Filing

Grawey Nathaniel A. 4

Accession 0001213900-25-112295

CIK 0001560293other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 8:01 PM ET

Size

8.1 KB

Accession

0001213900-25-112295

Insider Transaction Report

Form 4
Period: 2025-11-14
Grawey Nathaniel A.
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock Purchase Warrant

    2025-11-14+101,167101,167 total
    Exercise: $1.16From: 2025-11-14Exp: 2028-11-14Common Stock (101,167 underlying)
  • Purchase

    Common stock

    2025-11-14+101,167239,281 total
Holdings
  • Common stock

    (indirect: By SiVantage, Inc.)
    175,383
Footnotes (2)
  • [F1]On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.
  • [F2]Reflects the reporting person's indirect interest in 710, 300 shares owned by SiVantage, Inc., a corporation in which the reporting person has a 24.69% equity interest.

Documents

1 file

Issuer

Tenon Medical, Inc.

CIK 0001560293

Entity typeother

Related Parties

1
  • filerCIK 0002081212

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 8:01 PM ET
Size
8.1 KB